Pharmacoeconomic issues in bisphosphonate treatment of metastatic bone disease

被引：11

作者：

Hillner, BE

机构：

[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA

[2] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA

来源：

关键词：

D O I：

10.1053/sonc.2001.25432

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：64 / 68

页数：5

共 27 条

[1] Body Jean-Jacques, 2000, Cancer, V88, P3054, DOI 10.1002/1097-0142(20000615)88:12+<3054::AID-CNCR23>3.0.CO
[2] 2-Z
[3] A dose-finding study of zoledronate in hypercalcemic cancer patients
Body, JJ
Lortholary, A
Romieu, G
Vigneron, AM
Ford, J
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) : 1557 - 1561
[4] Current use of bisphosphonates in oncology
Body, JJ
Bartl, R
Burckhardt, P
Delmas, PD
Diel, IJ
Fleisch, H
Kanis, JA
Kyle, RA
Mundy, GR
Paterson, AHG
Rubens, RD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3890 - 3899
[5] BODY JJ, 1999, P AN M AM SOC CLIN, V18, pA575
[6] Economic impact of using clodronate in the management of patients with multiple myeloma
Bruce, NJ
McCloskey, EV
Kanis, JA
Guest, JF
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (02) : 358 - 364
[7] Clézardin P, 2000, JOINT BONE SPINE, V67, P22
[8] Uses and abuses of bisphosphonates
Coleman, RE
[J]. ANNALS OF ONCOLOGY, 2000, 11 : 179 - 184
[9] Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.3.CO
[10] 2-Z